These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8185337)

  • 1. [Early phase II study of KW-2307 in advanced or recurrent breast cancer. KW-2307 Cooperative Study Group (Breast Cancer Section].
    Tominaga T; Nomura Y; Adachi I; Takashima S; Kimura M; Koyama H; Toge T; Tamura K; Hayasaka H; Kunii Y
    Gan To Kagaku Ryoho; 1994 May; 21(6):801-8. PubMed ID: 8185337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Late phase II study of KW-2307 in advanced or recurrent breast cancer. KW-2307 Cooperative Study Group (Breast Cancer Section)].
    Tominaga T; Nomura Y; Adachi I; Aoyama H; Nagao K; Mitsuyama S; Nakamura Y; Ogita M; Sano M; Takashima S
    Gan To Kagaku Ryoho; 1994 May; 21(6):809-16. PubMed ID: 8185338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Late phase II clinical study of KW-2307 in advanced/recurrent breast cancer patients (II)].
    Tominaga T; Nomura Y; Horikoshi N; Takashima S; Kimura M; Koyama H; Kikkawa N; Toge T; Mitsuyama S; Morimoto T; Enomoto K; Wada T; Kimishima I; Niitani H;
    Gan To Kagaku Ryoho; 2005 Jul; 32(7):983-90. PubMed ID: 16044960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phase I clinical study on new vinca alkaloid derivative, KW-2307 (vinorelbine). KW-2307 Study Group].
    Niitani H; Furuse K; Fukuoka M; Hasegawa K; Taguchi T
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):177-87. PubMed ID: 8311488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Early phase II clinical study of KW-2307 in patients with lung cancer. Lung Cancer Section in KW-2307 Study Group].
    Furuse K; Ohta M; Fukuoka M; Kurita Y; Kobayashi K; Hasegawa K; Kimura I; Fujii M; Yoshida S; Kitamura S
    Gan To Kagaku Ryoho; 1994 May; 21(6):785-93. PubMed ID: 8185336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A late phase-II trial comparing KW-2307 with vindesine in non-small cell lung cancer (1). Lung cancer section in KW-2307 Study Group].
    Furuse K; Yamori S; Negoro S; Fukuoka M; Takada Y; Nakai Y; Ikegami H; Fujii M; Nakajima S; Katakami N
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):67-76. PubMed ID: 7826080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.
    Gasparini G; Caffo O; Barni S; Frontini L; Testolin A; Guglielmi RB; Ambrosini G
    J Clin Oncol; 1994 Oct; 12(10):2094-101. PubMed ID: 7931479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Late phase II clinical study of KW-2307 in previously untreated patients with non-small cell lung cancer. KW-2307 Study Group (Lung Cancer Group)].
    Furuse K; Kinuwaki E; Motomiya M; Nishiwaki H; Hasegawa K; Kobayashi K; Kurita Y; Ohta K; Fukuoka M; Nakajima S
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):1941-7. PubMed ID: 8085845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy.
    Fumoleau P; Delgado FM; Delozier T; Monnier A; Gil Delgado MA; Kerbrat P; Garcia-Giralt E; Keiling R; Namer M; Closon MT
    J Clin Oncol; 1993 Jul; 11(7):1245-52. PubMed ID: 8315421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phase-I clinical study of KW-2307 combined with cisplatin in non-small cell lung cancer patients].
    Yamamoto M; Ariyoshi Y; Hasegawa K; Kobayashi K; Fukuoka M; Kurita Y; Sakuma A; Furuse K; Niitani H
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):993-9. PubMed ID: 8002639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I/II trial of continuous infusion vinorelbine for advanced breast cancer.
    Toussaint C; Izzo J; Spielmann M; Merle S; May-Levin F; Armand JP; Lacombe D; Tursz T; Sunderland M; Chabot GG
    J Clin Oncol; 1994 Oct; 12(10):2102-12. PubMed ID: 7931480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial of afatinib plus vinorelbine in Japanese patients with advanced solid tumors, including breast cancer.
    Mukai H; Masuda N; Ishiguro H; Mitsuma A; Shibata T; Yamamura J; Toi M; Watabe A; Sarashina A; Uttenreuther-Fischer M; Ando Y
    Cancer Chemother Pharmacol; 2015 Oct; 76(4):739-50. PubMed ID: 26254023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A phase II study of DWA2114R, a new platinum complex for breast cancer].
    Aoyama H; Kubo K; Uchino J; Hayasaka H; Asaishi K; Izuo M; Ogawa M; Majima H; Yasutomi M; Wada T
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):1033-9. PubMed ID: 1626939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I study of vintriptol, a tryptophan ester of vinblastine.
    Oosterkamp HM; Vlasveld LT; Wanders J; Beijnen JH; van Tellingen O; Dubbelman AC; Simonetti GP; Franklin HR; Vermorken JB; Ten Bokkel Huinink WW
    Eur J Cancer; 1991; 27(10):1222-6. PubMed ID: 1835590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical phase I study of TNP-351. The TNP-351 Research Committee].
    Taguchi T; Niitani H; Furue H; Tsukagoshi S; Kanamaru R; Hasegawa K; Akazawa S; Yoneda S; Tominaga T; Sasaki T
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):259-71. PubMed ID: 7857102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter phase II study of weekly oral vinorelbine for stage IV non-small-cell lung cancer.
    Vokes EE; Rosenberg RK; Jahanzeb M; Craig JB; Gralla RJ; Belani CP; Jones SE; Bigley JW; Hohneker JA
    J Clin Oncol; 1995 Mar; 13(3):637-44. PubMed ID: 7533824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An early phase II study of CPT-11 (irinotecan hydrochloride) in patients with advanced breast cancer].
    Taguchi T; Yoshida Y; Izuo M; Ishida T; Ogawa M; Nakao I; Tominaga T; Ohkawa T; Oguro M; Yoshida M
    Gan To Kagaku Ryoho; 1994 Jan; 21(1):83-90. PubMed ID: 8291919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of vindesine in patients with advanced breast cancer.
    Walker BK; Raich PC; Fontana J; Subramanian VP; Rogers JS; Knost JA; Denning B
    Cancer Treat Rep; 1982 Sep; 66(9):1729-32. PubMed ID: 6288237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors.
    Rowinsky EK; Noe DA; Trump DL; Winer EP; Lucas VS; Wargin WA; Hohneker JA; Lubejko B; Sartorius SE; Ettinger DS
    J Clin Oncol; 1994 Sep; 12(9):1754-63. PubMed ID: 8083697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.